Gary Friedman

Company: Pfizer

Job title: Director, Inflammation & Immunology

Seminars:

Establishing Biomarker Panels to Improve Clinical Trial Design & Optimize Patient Safety 11:00 am

Learn about translational biomarker panel development and proactive communication with regulatory agencies Explore the “Pre-clinical to Clinical Learn-and-Confirm” Paradigm: Prior success to accelerate novel biomarker panel development and implementation Discover the biomarker data repository: sharing anonymized data to benefit patient care globally Examine longitudinal biomarker data sharing and biomarker dynamics in subgroups with and without…Read more

day: Track 1 - Day 1 AM

Panel Discussion: How can we Modernize Surrogate Endpoint Development? Moving Beyond Hard Endpoints 8:00 am

Evaluating novel surrogate endpoints in addition to emerging standard of care Non-invasive imaging, patient-reported outcomes, UACR, and more: what is an acceptable endpoint? Considering payers perspectives’ on moving beyond hard endpoints and ESRDRead more

day: Day One